Welcome & Introducation

Adjuvant Radiotherapy in Breast Cancer

MBC-To Operate the Primary or Not

Metastatic Breast cancer: PIKing the Correct mutation

Dattatreya Getting Real With Ribociclib: Bridging the RCT and RWE universe with evidence across 8000 patients

Panel Discussion | Sequencing agents for HR+VE MBC in clinical Practice: Perspectives and Considerations

PIKing The Right Strategyu for patients with HR+/HER2-, PIK3CA mutation

Closing Remarks